Anzeige
Mehr »
Login
Donnerstag, 28.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Spezial am Donnerstag: Rallye II. - Neuer Anstoß, News und was die Börsencommunity jetzt nicht verpassen will…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EWWY | ISIN: US92859E2072 | Ticker-Symbol:
NASDAQ
27.03.24
20:43 Uhr
4,700 US-Dollar
0,000
0,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
VIVOS THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
VIVOS THERAPEUTICS INC 5-Tage-Chart

Aktuelle News zur VIVOS THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
15.02.Vivos Therapeutics, Inc. - 8-K, Current Report1
15.02.Vivos Therapeutics announces exercise of warrants for proceeds of $4M1
12.02.Vivos Therapeutics CEO Kirk Huntsman Discusses FDA Approval and Market Disruptions1
06.02.Vivos Therapeutics, Inc: Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities553LITTLETON, Colo., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the "Company" or "Vivos") (NASDAQ:VVOS), a leading medical device and technology company specializing in the development...
► Artikel lesen
30.01.CRBP, PXLW and VVOS among mid-day movers6
08.01.Vivos Therapeutics, Inc: Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company's Proprietary Oral Medical Devices to Treat Severe OSA148New Dentist Inquiries Jumped 600% andSigned Dentist Enrollment Contracts up 38% Sequentially Over Q3 CARE Oral Medical Device Unit Orders Increased 26% Following FDA Clearance LITTLETON, Colo....
► Artikel lesen
11.12.23Vivos Therapeutics, Inc: Vivos Therapeutics Presents Groundbreaking Event: "Empowering Women to Champion Airway"207LITTLETON, Colo., Dec. 11, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the "Company" or "Vivos") (NASDAQ:VVOS), a leading medical device and technology company specializing in the development...
► Artikel lesen
30.11.23Vivos Therapeutics, Inc. - 8-K, Current Report1
30.11.23Vivos Therapeutics, Inc. - S-1/A, General form for registration of securities2
30.11.23Why Is Vivos Therapeutics (VVOS) Stock Down 35% Today?5
30.11.23Vivos Therapeutics +1.000%: Warum der Absturz nun bevorsteht408Vivos Therapeutics (WKN: A2QF3C), ein Spezialist für Atem- und Schlafprobleme, hat am Mittwoch ein Börsenbeben ausgelöst: Die Aktie des Unternehmens schoss in der Spitze um über +1.000% hoch, nachdem...
► Artikel lesen
29.11.23Vivos Therapeutics stock soars after FDA approval of sleep apnea device8
29.11.23Vivos Therapeutics' airway-opening oral devices snap up FDA nod for severe sleep apnea12
29.11.23Vivos Therapeutics hits major milestone with FDA clearance for treating severe sleep apnea7
29.11.23Why Is Vivos Therapeutics (VVOS) Stock Up 290% Today?5
29.11.23Why Is Sleep Disorder Device Provider Vivos Therapeutics Stock Trading Higher Today?3
29.11.23FDA clears oral device for sleep apnea from Vivos Therapeutics3
29.11.23US FDA clears Vivos Therapeutics' oral device treatment for sleep apnea5
29.11.23Vivos Therapeutics more than doubles as FDA clears sleep apnea device4
29.11.23Vivos Therapeutics, Inc: Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea265LITTLETON, Colo., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the "Company" or "Vivos") (NASDAQ:VVOS), a leading medical device and technology company specializing in the development...
► Artikel lesen
Seite:  Weiter >>
46 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1